MoeX

Mycobacterium Tuberculosis MoeX Recombinant
Cat. No.
BT25118
Source
Escherichia Coli.
Synonyms
Appearance
Sterile Filtered clear solution.
Purity

Protein is >95% pure as determined by 12% PAGE (coomassie staining).

Usage
THE BioTek's products are furnished for LABORATORY RESEARCH USE ONLY. The product may not be used as drugs, agricultural or pesticidal products, food additives or household chemicals.
Shipped with Ice Packs
In Stock

Description

Recombinant Mycobacterium Tuberculosis MoeX produced in E.Coli is a single, non-glycosylated, polypeptide chain having a molecular mass of 38 kDa.
The MoeX is fused to a His tag at C-terminus and purified by proprietary chromatographic techniques.

Product Specs

Description
Recombinant Mycobacterium Tuberculosis MoeX produced in E.Coli is a single, non-glycosylated polypeptide chain with a molecular mass of 38 kDa. The MoeX protein has a C-terminal His tag and is purified using proprietary chromatographic techniques.
Physical Appearance
Clear, sterile-filtered solution.
Stability
For short-term storage (up to 1 week), MoeX Recombinant is stable at 4°C. For long-term storage, store below -18°C. Avoid repeated freeze-thaw cycles.
Formulation
MoeX protein solution at a concentration of 0.75mg/ml. The solution is formulated in 1xPBS (phosphate-buffered saline) containing 25mM arginine and 0.02% NaN3 (sodium azide).
Purity
The purity of the MoeX protein is greater than 95% as determined by SDS-PAGE analysis (12% gel) with Coomassie blue staining.
Source
Escherichia Coli.

Product Science Overview

Introduction

Mycobacterium tuberculosis (Mtb) is the causative agent of tuberculosis (TB), a disease that remains a significant global health challenge. The development of recombinant proteins, such as MoeX, is crucial for understanding the biology of Mtb and for developing new diagnostic and therapeutic strategies.

Mycobacterium Tuberculosis

Mtb is a pathogenic bacterial species in the genus Mycobacterium and is characterized by its slow growth and complex cell wall structure. It primarily infects the lungs but can spread to other parts of the body. TB is transmitted through airborne particles, and despite the availability of treatment, it remains a leading cause of death worldwide.

MoeX Protein

MoeX is a protein encoded by the moeX gene in Mtb. This protein is involved in the biosynthesis of molybdopterin, a cofactor required for the activity of various enzymes, including those involved in the bacterial respiratory chain. The study of MoeX and its recombinant form is essential for understanding the metabolic pathways of Mtb and for identifying potential targets for drug development.

Recombinant Protein Production

Recombinant proteins are produced by inserting the gene encoding the protein of interest into a suitable expression system, such as Escherichia coli. The recombinant MoeX protein can then be purified and studied in vitro. This approach allows researchers to investigate the protein’s structure, function, and interactions with other molecules.

Applications and Significance
  1. Drug Development: Understanding the role of MoeX in Mtb metabolism can help identify new drug targets. Inhibitors of MoeX could potentially disrupt the bacterial respiratory chain, leading to the development of novel anti-TB therapies.
  2. Diagnostics: Recombinant MoeX can be used to develop diagnostic tests for TB. For example, it can be employed in enzyme-linked immunosorbent assays (ELISAs) to detect antibodies against Mtb in patient samples.
  3. Research: Studying recombinant MoeX provides insights into the fundamental biology of Mtb. This knowledge can contribute to the broader understanding of bacterial pathogenesis and resistance mechanisms.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2024 Thebiotek. All Rights Reserved.